Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft Model

PLoS ONE - United States
doi 10.1371/journal.pone.0030207
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

STAT3 Signaling Is Activated Preferentially in Tumor-Initiating Cells in Claudin-Low Models of Human Breast Cancer

Stem Cells
MedicineMolecular MedicineDevelopmental BiologyCell Biology
2014English

Small Molecule Antagonists of the WNT/Beta-Catenin Signaling Pathway Target Breast Tumor-Initiating Cells in a Her2/Neu Mouse Model of Breast Cancer

PLoS ONE
Multidisciplinary
2012English

CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor-Negative Breast Cancer

Cancer Research
Cancer ResearchOncology
2010English

Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients With Pancreatic Ductal Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2016English

CD133+ Brain Tumor-Initiating Cells Are Dependent on STAT3 Signaling to Drive Medulloblastoma Recurrence

Oncogene
Cancer ResearchGeneticsMolecular Biology
2016English

Identification of Tumor-Initiating Cells in a P53-Null Mouse Model of Breast Cancer

Cancer Research
Cancer ResearchOncology
2008English

A Small Molecule Inhibitor of ETV1, YK-4-279, Prevents Prostate Cancer Growth and Metastasis in a Mouse Xenograft Model

PLoS ONE
Multidisciplinary
2014English

Stretching Reduces Tumor Growth in a Mouse Breast Cancer Model

Scientific Reports
Multidisciplinary
2018English

Identifying and Targeting Tumor-Initiating Cells in the Treatment of Breast Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy